Bellevue Group Ag Sangamo Therapeutics, Inc Transaction History

Bellevue Group Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $35.5 Million - $70 Million	-3,850,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $1.61 Million - $2.34 Million	200,000 Added 5.48%	3,850,000 $32.2 Million
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $31.9 Million - $47.6 Million	3,650,000 New	3,650,000 $39.3 Million

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $294M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.